Pablo R Brumovsky

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology

ACS chemical neuroscience

Development (Cambridge, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Pablo R Brumovsky, Mariano Asla, Marcelo J Villar
Chronic pain: try new routes to more tailored treatments. Nature 617 (7961) (2023)
Pablo R Brumovsky, Mariano Asla, Marcelo J Villar
Chronic pain: try new routes to more tailored treatments. Nature 617 (7961) (2023)
Antonella S Ríos, Ana Paula De Vincenti, Mailin Casadei, Jorge Benjamin Aquino, Pablo R Brumovsky, Gustavo Paratcha, Fernanda Ledda
Etv4 regulates nociception by controlling peptidergic sensory neuron development and peripheral tissue innervation. Development (Cambridge, England) 149 (16) (2022)
C Leiguarda, A Villarreal, C Potilinski, T Pelissier, M F Coronel, J Bayo, A J Ramos, A Montaner, M J Villar, L Constandil, Pablo R Brumovsky
Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (2021)
Candelaria Leiguarda, Carly J McCarthy, Mailin Casadei, Kerstin H Lundgren, María Florencia Coronel, Harry Trigosso-Venario, Rebecca P Seal, Kim B Seroogy, Pablo R Brumovsky
Transcript Expression of Vesicular Glutamate Transporters in Rat Dorsal Root Ganglion and Spinal Cord Neurons: Impact of Spinal Blockade during Hindpaw Inflammation. ACS chemical neuroscience 11 (17) (2020)
Candelaria Leiguarda, Constanza Potilinski, Julia Rubione, Pablo Tate, Marcelo J Villar, Alejandro Montaner, Verónica Bisagno, Luis Constandil, Pablo R Brumovsky
IMT504 Provides Analgesia by Modulating Cell Infiltrate and Inflammatory Milieu in a Chronic Pain Model. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 16 (3) (2020)